Relationship between the se of statins and patient survival in colorectal cancer: A systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Cai, Heping ^a   Zhang, Gongwu ^a   Wang, Zhuo ^b   Luo, Zhihong ^a   Zhou, Xiaochun ^c  

^a Anhui Provincial Children's Hospital   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Lianyungang Oriental Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER SURVIVOR; COLORECTAL CANCER; DISEASE FREE SURVIVAL; HUMAN; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PREOPERATIVE EVALUATION; RECURRENCE FREE SURVIVAL; SURVIVAL TIME; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; COLORECTAL NEOPLASMS; META ANALYSIS; PUBLISHING; SURVIVAL ANALYSIS;

COLORECTAL NEOPLASMS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PUBLICATION BIAS; SURVIVAL ANALYSIS;

EID: 84931264369     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126944     Document Type: Article

References (37)

1. Serruys PW, de Feyter P, Macaya C, Kokott N, Puel J, Vrolix M, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. Jama. 2002; 287: 3215-3222. PMID: 12076217
2. Tonkin A, Simes R J, Sharpe N, and Thomson A. The long intervention with pravastatin in ischaemic disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The New England journal of medicine. 1998; 339: 1349-1357. PMID: 9841303
3. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. The New England journal of medicine. 1996; 335: 1001-1009. PMID: 8801446
4. Jakobisiak M and Golab J. Potential antitumor effects of statins (Review). International journal of oncology. 2003; 23: 1055-1069. PMID: 12963986
5. Carlberg M, Dricu A Fau - Blegen H, Blegen H Fau - Wang M, Wang M Fau - Hjertman M, Hjertman M Fau - Zickert P, Zickert P Fau - Hoog A, et al. Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface. Evidence for a new link between 3-hydroxy-3-methylglutaryl-coenzyme a reductase and cell growth. J Biol Chem. 1996; 271: 17453-17462. PMID: 8663239
6. Pradelli D, Soranna D, Scotti L, Zambon A, Catapano A, Mancia G, et al. Statins and primary liver cancer: a meta-analysis of observational studies. Eur J Cancer Prev. 2013; 22: 229-234. doi: 10.1097/CEJ.0b013e328358761a PMID: 23010949
7. Zhang XL, Geng J Fau - Zhang Xiao-penp, Zhang Xp Fau - Peng Bo, Peng B Fau - Che Jian-ping, Che Jp Fau - Yan Yang, Yan Y Fau - Wang Guang-chun, Wang Gc Fau - Xia Sheng-qiang, et al. Statin use and risk of bladder cancer: a meta-analysis. Cancer Causes Control. 2013; 24(4): 769-776. doi: 10.1007/s10552-013-0159-3 PMID: 23361339
8. Singh PP and Singh S. Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis. Annals of oncology.2013; 24: 1721-1730. doi: 10.1093/annonc/mdt150 PMID: 23599253
9. Liu Y, Tang W Fau - Wang Jian, Wang J Fau - Xie Li, Xie L Fau - Li Taijie, Li T Fau - He Yu, He Y Fau - Deng Yan, et al. Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies. Cancer Causes Control. 2014; 25(2): 237-49. doi: 10.1007/s10552-013-0326-6 PMID: 24265089
10. Liu Y, Qin A, Li T, Qin X and Li S. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials. Gynecologic oncology. 2014; 133: 647-655. doi: 10.1016/j.ygyno.2014.04.007 PMID: 24736024
11. Wang J, Li C Fau - Tao Haitao, Tao H Fau - Cheng Yao, Cheng Y Fau - Han Lu, Han L Fau - Li Xiaoyan, Li X Fau - Hu Yi, et al. Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials. PLoS One,2013; 8: e77950. doi: 10.1371/journal.pone.0077950 PMID: 24205041
12. Siddiqui AA, Nazario H Fau - Mahgoub Amar, Mahgoub A Fau - Patel Mahir, Patel M Fau - Cipher Daisha, Cipher D Fau - Spechler Stuart J, Spechler SJ. For patients with colorectal cancer, the long-term use of statins is associated with better clinical outcomes. Dig Dis Sci. 2009; 54(6):1307-1311. doi: 10.1007/s10620-009-0790-8 PMID: 19337834
13. Wu J, Wong WW, Khosravi F, Minden MD and Penn LZ. Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis. Cancer research2004; 64:6461-6468. PMID: 15374955
14. Ukomadu C and Dutta A. p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases. J Biol Chem. 2003; 278(44):43586-94 PMID: 12930830
15. Agarwal B, Halmos B, Feoktistov AS, Protiva P, Ramey WG, Chen M, et al. Mechanism of lovastatininduced apoptosis in intestinal epithelial cells. Carcinogenesis. 2002; 23: 521-528. PMID: 11895868
16. Narisawa T, Morotomi M, Fukaura Y, Hasebe M, Ito M, Aizawa R. (1996) Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. Japanese journal of cancer research: Gann 87: 798-804. PMID: 8797885
17. Habis M, Wroblewski K, Bradaric M, Ismail N, Yamada SD, Litchfield L, Lengyel E, Romero IL. Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis. PLoS One. 2014; 9: e104521. doi: 10.1371/journal.pone.0104521 PMID: 25118694
18. Song C, Park S Fau - Park Jinsung, Park J Fau - Shim Myungsun, Shim M Fau - Kim Aram, Kim A Fau - Jeong InGab, Jeong Ig Fau - Hong Jun Hyuk, et al. Statin use after radical prostatectomy reduces biochemical recurrence in men with prostate cancer. Prostate. 2014; Oct 18. doi: 10.1002/pros.22907
19. Choi SK, Min GE, Jeon SH, Lee HL, Chang SG, Yoo KH.Effects of statins on the prognosis of local and locally advanced renal cell carcinoma following nephrectomy. Molecular and clinical oncology. 2013; 1: 365-368. PMID: 24649176
20. Livingstone E, Hollestein Lm Fau - van Herk-Sukel Myrthe PP, van Herk-Sukel Mp Fau - van de Poll-Franse Lonneke, van de Poll-Franse L Fau - Joosse Arjen, Joosse A Fau - Schilling Bastian, Schilling B Fau Nijsten Tamar, et al. Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study. Cancer Med. 2014; 3: 1284-93. doi: 10.1002/cam4.285 PMID: 24935402
21. Lakha F, Theodoratou E Fau - Farrington Susan M, Farrington Sm Fau - Tenesa Albert, Tenesa A Fau - Cetnarskyj Roseanne, Cetnarskyj R Fau - Din Farhat VN, Din Fv Fau - Porteous Mary E, Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage. BMC Cancer. 2012; 12:487. doi: 10.1186/1471-2407-12-487 PMID: 23088590
22. Cardwell CR, Hicks BM, Hughes C and Murray LJ. Statin use after colorectal cancer diagnosis and survival: a population-based cohort study. J Clin Oncol. 2014; 32(28):3177-3183. doi: 10.1200/JCO.2013.54.4569 PMID: 25092779
23. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology. 2010; 25: 603-605. doi: 10.1007/s10654-010-9491-z PMID: 20652370
24. Nielsen SF, Nordestgaard Bg Fau - Bojesen SE and Bojesen SE. Statin use and reduced cancer-related mortality. N Engl J. 2012; 367(199):1792-1802. doi: 10.1056/NEJMp1206845 PMID: 22747178
25. Ng K, Ogino S Fau - Meyerhardt JA, Meyerhardt Ja Fau - Chan JA, Chan Ja Fau - Chan AT, Chan At Fau - Niedzwiecki D, Niedzwiecki D Fau - Hollis, et al. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. J Natl Cancer Inst. 2011; 103: 1540-1551. doi: 10.1093/jnci/djr307 PMID: 21849660
26. Mace AG, Gantt Ga Fau - Skacel M, Skacel M Fau - Pai R, Pai R Fau - Hammel JP, Hammel Jp Fau - Kalady MF, Kalady MF. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer. Dis Colon Rectum. 2013; 56(11):1217-1227. doi: 10.1097/DCR.0b013e3182a4b236 PMID: 24104995
27. Ma WL, Shao YY, Hsu CH, Yeh KH, Chen HM, Yeh YC, et al. Regular statin users and colorectal cancer (CRC) prognosis. Journal of Clinical Oncology. 2013; 31.
28. Popat S, Hubner R and Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2005; 23: 609-618.
29. Jensen AB, Larsen M, Gislum M, Skriver MV, Jepsen P, Norgaard B, et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. The American journal of gastroenterology. 2006; 101: 1283-1287. PMID: 16771950
30. Walker KG, Bell Sw Fau - Rickard MJFX, Rickard Mj Fau - Mehanna D, Mehanna D Fau - Dent OF, Dent Of Fau - Chapuis PH, Chapuis Ph Fau - Bokey EL, et al. Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg. 2004; 240:255-259. PMID: 15273549
31. Popat S and Houlston RS. A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer, 2005; 41(14): 2060-2070. PMID: 16125380
32. Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, et al. Statins and the risk of colorectal cancer. The New England journal of medicine. 2005; 352: 2184-2192. PMID: 15917383
33. Coogan PF, Smith J Fau - Rosenberg L and Rosenberg L. Statin use and risk of colorectal cancer. J Natl Cancer Inst. 2007; 99(1):32-40. PMID: 17202111
34. Kaye JA and Jick H. Statin use and cancer risk in the General Practice Research Database. Br J Cancer. 2004; 90:635-637. PMID: 14760377
35. Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ.1997; 315: 629-634. PMID: 9310563
36. Lee JE, Baba Y Fau - Ng K, Ng K Fau - Giovannucci E, Giovannucci E Fau - Fuchs CS, Fuchs Cs Fau - Ogino S, Ogino S Fau - Chan Andrew, et al. Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies. Cancer Prev Res. 2011; 4(11): 1808-1815. doi: 10.1158/1940-6207.CAPR-11-0113 PMID: 21680706
37. Bonovas S, Filioussi K Fau - Flordellis CS, Flordellis Cs Fau - Sitaras NM and Sitaras NM. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Cin Oncol. 2007; 25(23):3462-3468. PMID: 17687150